文献速递慢性肾脏病肾移植

在老年1型糖尿病患者中评估基于肌酐、胱抑素C和β2微球蛋白的GFR估算方程

Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes.
PubMed 文献 · Kidney Int Rep · 2019-02-21

该研究纳入66例病程≥50年的1型糖尿病老年患者和73名年龄性别匹配的非糖尿病对照,以菊粉清除率测量的GFR为参考,评估基于肌酐、胱抑素C和β2微球蛋白的eGFR方程的性能。结果显示除β2微球蛋白外所有方程均显著低估mGFR,胱抑素C方程偏差最大,β2微球蛋白精确度最低。

要点

  • 除β2微球蛋白外,其他eGFR方程均显著低估老年1型糖尿病患者的mGFR。
  • 基于胱抑素C的方程偏差最大,且在老年亚组中偏差更大、准确性更低。
  • β2微球蛋白偏差最小但精确度最差,在1型糖尿病患者中性能更低。

核心结论

  • 老年人群需要更准确的GFR估算方法,尤其是1型糖尿病病程≥50年者。

研究设计与样本

  • 研究纳入66例1型糖尿病病程≥50年的成人及73名年龄性别匹配的非糖尿病对照,平均年龄65±8岁,女性占55%。
  • 以菊粉清除率测量的GFR为参考,评估基于肌酐、胱抑素C和β2微球蛋白的eGFR方程。

主要发现

  • 平均mGFR为104±18 ml/min/1.73 m2,1型糖尿病组与对照组无显著差异(103±17 vs 105±19 ml/min/1.73 m2,P=0.39)。
  • 所有方程均显著低估mGFR(偏差-15至-30 ml/min/1.73 m2,P<0.001),但β2微球蛋白偏差为1.9 ml/min/1.73 m2(P=0.61)。
  • 胱抑素C方程偏差最大,β2微球蛋白精确度最低(SD 43.5 ml/min/1.73 m2,P<0.001),CKD-EPIcysC准确性最低(69.1%,P<0.001)。
  • 胱抑素C方程在<60、60-69、≥70岁亚组中偏差更大、准确性更低,所有方程在mGFR较高范围(60-89、90-119、≥120 ml/min/1.73 m2)偏差更大。

临床怎么用

  • 在老年1型糖尿病患者中解读eGFR时需注意方程可能显著低估mGFR。
  • 基于胱抑素C的方程偏差较大,临床决策时应谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Glomerular filtration rate (GFR) is routinely used for clinical assessment of kidney function. However, the accuracy of estimating equations in older adults is uncertain. METHODS: In 66 adults with ≥50 years type 1 diabetes (T1D) duration and 73 nondiabetic controls from age/sex-matched subgroups (65 ± 8 years old and 77[55%] were women) we evaluated the performance of estimated GFR (eGFR) by creatinine (Modification of Diet and Renal Disease [MDRD], Chronic Kidney Disease-Epidemiology [CKD-EPI]cr), cystatin C (CKD-EPIcys, CKD-EPIcr-cys), and β2-microglobulin (β2M) compared with measured GFR by inulin clearance (mGFR). Performance was evaluated using metrics of bias (mean difference), precision (SD), and accuracy (proportion of eGFR that differed by >20% of mGFR). RESULTS: Mean mGFR was 104 ± 18 ml/min per 1.73 m2 (range: 70-154 ml/min per 1.73 m2) and was not different between T1D and controls (103 ± 17 vs. 105 ± 19 ml/min per 1.73 m2, P = 0.39). All equations significantly underestimated mGFR (bias: -15 to -30 ml/min per 1.73 m2, P < 0.001 for all comparisons) except for β2M, which had bias of 1.9 ml/min per 1.73 m2 (P = 0.61). Bias was greatest in cystatin C-based equations. Precision was lowest for β2M (SD: 43.5 ml/min per 1.73 m2, P < 0.001 for each comparison). Accuracy was lowest for CKD-EPIcysC (69.1%, P < 0.001 for each comparison). Cystatin C-based equations demonstrated greater bias and lower accuracy in older age subgroups (<60, 60-69, ≥70 years). All equations demonstrated greater bias across higher ranges of mGFR (60-89, 90-119, ≥120 ml/min per 1.73 m2). Results were similar between T1D and controls except that β2M had lower performance in T1D. CONCLUSION: Better estimates of GFR in older adults are needed for research and clinical practice, as this subgroup of the population has an amplified risk for the development of chronic kidney disease (CKD) that requires accurate GFR estimation methods.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Scarr D, Bjornstad P, Lovblom LE, et al. Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes. Kidney Int Rep. 2019. PMID: 31194091. doi:10.1016/j.ekir.2019.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。